These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7787439)

  • 1. Patient treated solely with thyroid hormone.
    VanderLaan WP
    Thyroid; 1995 Feb; 5(1):75-6. PubMed ID: 7787439
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Thyroid suppression.
    Hill LD; Beebe HG; Hipp R; Jones HW
    Arch Surg; 1974 Apr; 108(4):403-5. PubMed ID: 4815915
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal treatment of differentiated thyroid neoplasms].
    Ferrini O; Biassoni P; Bagnasco M; Santaniello B
    Arch Maragliano Patol Clin; 1978; 34(1):37-46. PubMed ID: 583618
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of the treatment of 222 patients with malignant tumours of the thyroid gland.
    Taylor S; Davis PW
    Monogr Neoplast Dis Var Sites; 1970; 6():243-58. PubMed ID: 5527676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hormonal therapy in differentiated carcinoma of the thyroid gland].
    Francia G; Davì MV; Petroziello A; Sussi PL
    Chir Ital; 1994; 46(4):56-8. PubMed ID: 7882445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.
    Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK
    Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudotumor cerebri and thyroid-replacement therapy in patients affected by differentiated thyroid carcinoma.
    Panza N; De Rosa M; Lombardi G; Salvatore M
    J Endocrinol Invest; 1985 Aug; 8(4):357-8. PubMed ID: 4067207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid carcinoma in childhood.
    Anger K; Feine U
    Prog Pediatr Surg; 1983; 16():39-42. PubMed ID: 6878727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of differentiated thyroid carcinomas. Prospective study].
    Gemsenjäger E; Staub JJ; Heitz PU
    Schweiz Med Wochenschr; 1985 Feb; 115(5):153-9. PubMed ID: 3975583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma.
    Cady B; Cohn K; Rossi RL; Sedgwick CE; Meissner WA; Werber J; Gelman RS
    Surgery; 1983 Dec; 94(6):978-83. PubMed ID: 6648813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 131I in the treatment of well differentiated thyroid cancer.
    Woodrum DT; Gauger PG
    J Surg Oncol; 2005 Mar; 89(3):114-21. PubMed ID: 15719384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of suppressive therapy with levothyroxine on the reduction of serum thyroglobulin after total thyroidectomy.
    Rosario P; Borges M; Reis J; Alves MF
    Thyroid; 2006 Feb; 16(2):199-200. PubMed ID: 16676413
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing end results in patients with papillary carcinoma of the thyroid.
    Crile G
    Surg Gynecol Obstet; 1971 Mar; 132(3):460-8. PubMed ID: 5546300
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thyroid neoplasms: treatment with thyroid hormones after thyroidectomy (author's transl)].
    Horster FA
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):691-3. PubMed ID: 7111188
    [No Abstract]   [Full Text] [Related]  

  • 16. TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma.
    Busnardo B; Vagelista R; Girelli ME; Bui F; Lazzi C
    J Clin Endocrinol Metab; 1976 May; 42(5):901-6. PubMed ID: 818103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic borderline situations in papillary carcinoma of the thyroid].
    Schumann J
    Dtsch Med Wochenschr; 1977 Sep; 102(37):1324-8. PubMed ID: 902600
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic strategy in thyroid carcinoma].
    Baschieri L; Antonelli A; Del Guerra P
    Clin Ter; 1987 Jun; 121(6):457-65. PubMed ID: 2973881
    [No Abstract]   [Full Text] [Related]  

  • 19. The endocrine dependency of papillary carcinomas of the thyroid.
    Crile G
    Monogr Neoplast Dis Var Sites; 1970; 6():269-75. PubMed ID: 5527678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long term follow-up after thyroidectomy].
    Scazziga BR
    Helv Chir Acta; 1978 Jan; 44(5-6):741-5. PubMed ID: 580089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.